Cephalon Hopes To Market Provigil With Anesta Actiq To Oncologists

Cephalon hopes eventually to market the narcolepsy treatment Provigil to oncologists using the sales force that details Anesta's breakthrough cancer pain treatment Actiq, following a merger between the two companies.